HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

NCT06333561 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Lenvatinib
PD-1 Inhibitor
Hepatic Arterial Infusion Chemotherapy

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Lenvatinib
DRUG: Tislelizumab
DRUG: Toripalimab
DRUG: Sintilimab
DRUG: Camrelizumab

Sponsor

Sun Yat-sen University